ValuEngine Lowers Tate & Lyle (OTCMKTS:TATYY) to Sell

Share on StockTwits

Tate & Lyle (OTCMKTS:TATYY) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday, ValuEngine reports.

TATYY has been the subject of a number of other reports. Jefferies Financial Group upgraded shares of Tate & Lyle from an “underperform” rating to a “hold” rating in a research report on Sunday. Goldman Sachs Group raised shares of Tate & Lyle from a “neutral” rating to a “buy” rating in a report on Monday, November 25th. Finally, Zacks Investment Research downgraded Tate & Lyle from a “hold” rating to a “sell” rating in a research report on Thursday, November 7th.

OTCMKTS TATYY traded down $0.05 on Wednesday, hitting $39.75. The stock had a trading volume of 5,976 shares, compared to its average volume of 10,389. Tate & Lyle has a 52-week low of $33.68 and a 52-week high of $41.20. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.97 and a current ratio of 1.61. The company has a market capitalization of $4.66 billion, a price-to-earnings ratio of 14.56, a price-to-earnings-growth ratio of 8.63 and a beta of 0.54. The firm has a 50-day moving average of $36.59 and a 200-day moving average of $36.50.

Tate & Lyle Company Profile

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products.

Featured Story: Buyback For Investors Defined

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.